Page 7 - Van Cutsem News Today

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced updated data from its Phase 1b CodeBreaK 101 study, one of the most comprehensive global clinical...

Next trial in RAS-mutated mCRC (ONSEMBLE) is a randomized Phase 2 trial to demonstrate onvansertibs contribution to SoC and position for a possible...

Get current regimens for occult primary tumors, such as adenocarcinoma or carcinoma not otherwise specified (NOS) and more.

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced results from KRYSTAL-1, a multicohort...

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced results from KRYSTAL-1, a multicohort...

STOCKHOLM, June 9, 2022 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day on Thursday, June 16, 2022 at 09:00 AM EDT (3:00 PM CET), focusing

/PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day on Thursday, June 16, 2022 at 09:00 AM EDT (3:00 PM...

Halfway through the major events marking Queen Elizabeth's Platinum Jubilee, there is a sense that the recognition of her seven decades on the throne has become a chance to both honour her and contemplate the monarchy of the future.

Buckingham Palace balcony appearances are a hotly contested chance for the British public to nab a glimpse at the entire royal family together.
But every n

The four-year-old royal chatted to the Queen and covered his ears during the flypast.